Unity Biotechnology, Inc. Proceeds from Stock Options Exercised
Unity Biotechnology, Inc. reported Proceeds from Stock Options Exercised of $27.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-06-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2018-06-07
- Unity Biotechnology, Inc. proceeds from stock options exercised for the quarter ending 2018-03-31 was $27.00K, a 1250.00% increase year-over-year.
- Unity Biotechnology, Inc. proceeds from stock options exercised for the quarter ending 2017-03-31 was $2.00K.
| Period end | Proceeds from Stock Options Exercised 3 month |
|---|---|
| 2018-03-31 | $27.00K 10-Q · filed 2018-06-07 |
| 2017-03-31 | $2.00K 10-Q · filed 2018-06-07 |